Buck Institute and Sens.ai collaborate on brain aging study

New longevity tech collaboration will research and develop first-ever biological clock for the brain.

Sens.ai, a brain coaching platform that leverages neurotech and AI to improve cognitive healthspan, and Eric Verdin, President and CEO of the Buck Institute for Research on Aging have announced a collaboration to spearhead scientific advancement in brain health and longevity. Together, they plan to research and develop a biological clock designed to measure brain age – a move they hope will catalyze a shift in the understanding and treatment of age-related neurological decline.

Longevity.Technology: The collaboration is based on the hypothesis that the advanced Sens.ai neurotechnology platform can accurately capture biomarkers relevant to quantifying brain age and implement brain training interventions to reverse the brain aging process. Both parties are united in their mission to mitigate the effects of aging and extend human healthspan; the Buck Institute brings a rich legacy of innovative research, state-of-the-art facilities, and decades of expertise in the field of aging, while Sens.ai brings its cutting-edge commercial neurotechnology platform to the table, a platform that features patent-pending hardware and software designed for high-integrity data capture and scalable discovery. Exciting times are ahead!

“We’re thrilled to join forces with the world-renowned Buck Institute and its all-star team of scientists led by Dr Eric Verdin,” said Paola Telfer, Founder and CEO of Sens.ai.

“This collaboration intersects our groundbreaking neurotechnology with the Buck Institute’s research in a synergistic way that can rapidly accelerate insights and developments to help extend healthspan for people everywhere.”

Buck Institute researchers reveal mechanism linking NAD+ to fertility problems
Eric Verdin is President and CEO of the Buck Institute

“Sens.ai’s technology is a breakthrough that can help us gather the right biomarkers with high integrity to conduct the analytics and research required to progress the longevity field in the area of the brain which is the next frontier,” said Verdin.

By integrating Sens.ai’s personalized light stimulation, neurofeedback, heart coherence training, and high-fidelity biosignal capture and brain function testing with the Buck’s research expertise and scientific resources, the collaboration aims to accelerate scalable discoveries in the longevity field. This collaboration should create a synergy that will do that at speed, accelerating discovery and developments in the brain aging field that can be of benefit to a great number of people.